New Delhi: The country may soon get its first indigenous vaccine against cervical cancer. In fact, the central government is considering including the Quadrivalent Human Papillomavirus Vaccine (qHPV) in the national vaccination ceremony to combat cervical cancer. The vaccine has been developed by the Serum Institute of India (SII).
It is being said that on August 15, Prime Minister Modi can also make an announcement about it. Prakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India, has written to the Union Health Ministry stating that the company can supply one crore doses of qHPV by December 2022. The Centre plans to give the vaccine to girls aged 9-14 years in the national immunisation programme. However, it can take up to 6 months to start. At present, India is dependent on HPV vaccines coming from abroad. It costs Rs 4000 per dose. Sources said that the Serum vaccine is likely to be at a much cheaper price in India.
Recently, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India to make a vaccine against cervical cancer. This vaccine has been named Cervavac. The vaccine is expected to strike the market by the end of this year. Phase 2 and 3 trials of this vaccine have been done. It is claimed that in the trial, this vaccine has proved effective on women of all age groups. This vaccine has shown an effect on all types of HPV infections.
Is it necessary to buy tricolour for free ration? Govt said- 'no such order...'
DGCA's big announcement about transgenders
Jagdeep Dhankhar to take oath as Vice President today, pays tribute to Bapu at Rajghat